‘Confusing blur’ between genuine medicines shortages and procurement issues, says wholesalers trade body

Speaking at the Healthcare Distribution Association annual conference, executive director Martin Sawer explained that medicines shortages were not always a result of “genuine pharmaceutical unavailability” but could be caused by incentives in medicines procurement.
Photo of Martin Sawer, executive director of the Healthcare Distribution Association, on a cityscape background
Martin Sawer told the conference that those involved in the supply chain need to share more about what is being done to maintain medicine supply to build trust with clinicians and patients

Healthcare Distribution Association (HDA UK)

Martin Sawer, executive director of the Healthcare Distribution Association (HDA), has said that there is a “confusing blur” between medicines shortages and the procurement of medicines.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated